Selexipag 1000 mcg Oral Tablet
RxNorm 1729007
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1729007 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: selexipag 1000 mcg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Selexipag 1 mg Oral Tablet
(Atom ID: 7719180)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely selexipag 1 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 12666082)
PTPrescribable
Designated preferred name (PT):
Selexipag 1 mg oral tablet
(Atom ID: 12666238)
PSNPrescribable
Prescribable Name (PSN):
Selexipag 1000 mcg Oral Tablet
(Atom ID: 7719191)
SYPrescribable
Synonym (SY):
Selexipag 1000 mcg Oral Tablet
(Atom ID: 7719192)
Patient Education
Selexipag
Selexipag is used in adults to treat pulmonary arterial hypertension (PAH, high blood pressure in the vessels that carry blood to the lungs) to slow down the worsening of symptoms and reduce the chance of being hospitalized for PAH. Selexipag is in a class of medications called selective nonprostanoid IP prostacyclin receptor agonists. It works by relaxing the blood vessels in the lungs to allow blood to flow easily.
[Learn More]
* Please review the disclaimer below.